VRTX VERTEX PHARMACEUTICALS INC More: the full row for VERTEX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 129,314 shares; 2026Q2: 201,791 shares; 2026Q3: 132,896 shares 132,896 $69.5M 13.73% -68,895 Timeline LLY ELI LILLY & CO More: the full row for ELI LILLY & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 63,284 shares; 2026Q1: 61,795 shares; 2026Q2: 76,532 shares; 2026Q3: 51,015 shares 51,015 $59M 11.66% -25,517 Timeline TEVA TEVA PHARMACEUTICAL INDS LTD More: the full row for TEVA PHARMACEUTICAL INDS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,423,116 shares; 2025Q1: 1,061,008 shares; 2025Q2: 2,046,846 shares; 2025Q3: not reported; 2025Q4: 1,435,865 shares; 2026Q1: 1,021,008 shares; 2026Q2: 746,835 shares; 2026Q3: 1,223,725 shares 1,223,725 $48.5M 9.57% +476,890 Timeline AMRX AMNEAL PHARMACEUTICALS INC More: the full row for AMNEAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,326,733 shares 2,326,733 $46.9M 9.26% new Timeline DXCM DEXCOM INC More: the full row for DEXCOM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 421,600 shares; 2026Q1: 698,158 shares; 2026Q2: 820,479 shares; 2026Q3: 489,400 shares 489,400 $42.2M 8.34% -331,079 Timeline JAZZ JAZZ PHARMACEUTICALS PLC More: the full row for JAZZ PHARMACEUTICALS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 161,812 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 158,663 shares; 2026Q2: 221,720 shares; 2026Q3: 160,321 shares 160,321 $37.1M 7.33% -61,399 Timeline ARGX ARGENX SE More: the full row for ARGENX SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 58,258 shares; 2025Q1: 17,844 shares; 2025Q2: 47,793 shares; 2025Q3: 43,411 shares; 2025Q4: 37,653 shares; 2026Q1: 31,635 shares; 2026Q2: 41,596 shares; 2026Q3: 30,399 shares 30,399 $29.1M 5.76% -11,197 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 258,740 shares; 2026Q3: 118,384 shares 118,384 $27M 5.33% -140,356 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 249,769 shares; 2025Q1: 101,240 shares; 2025Q2: 157,861 shares; 2025Q3: 292,137 shares; 2025Q4: 201,627 shares; 2026Q1: 62,116 shares; 2026Q2: 219,308 shares; 2026Q3: 143,338 shares 143,338 $26.4M 5.22% -75,970 Timeline JNJ JOHNSON & JOHNSON More: the full row for JOHNSON & JOHNSON Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 302,831 shares; 2025Q4: 603,143 shares; 2026Q1: 414,503 shares; 2026Q2: 424,945 shares; 2026Q3: 73,559 shares 73,559 $19.5M 3.85% -351,386 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 866,716 shares; 2026Q3: 410,236 shares 410,236 $18.8M 3.72% -456,480 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 122,187 shares; 2025Q4: 120,921 shares; 2026Q1: 70,370 shares; 2026Q2: 47,026 shares; 2026Q3: 33,000 shares 33,000 $17.9M 3.53% -14,026 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 47,472 shares; 2025Q1: 37,869 shares; 2025Q2: 97,765 shares; 2025Q3: 67,706 shares; 2025Q4: 86,023 shares; 2026Q1: 103,288 shares; 2026Q2: 68,273 shares; 2026Q3: 33,668 shares 33,668 $17M 3.35% -34,605 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 202,618 shares 202,618 $16.1M 3.18% new Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,867 shares; 2025Q4: 622,403 shares; 2026Q1: 145,543 shares; 2026Q2: 120,712 shares; 2026Q3: 177,225 shares 177,225 $15.6M 3.08% +56,513 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 151,822 shares; 2026Q3: 40,019 shares 40,019 $8.21M 1.62% -111,803 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 369,588 shares; 2026Q2: 162,996 shares; 2026Q3: 144,406 shares 144,406 $5.5M 1.09% -18,590 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 90,107 shares 90,107 $1.86M 0.37% new Timeline